FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220821037> ?p ?o ?g. }

• W4220821037 endingPage "1068" @default.
• W4220821037 startingPage "1058" @default.
• W4220821037 abstract "Background and Aims Patients with severe alcohol-associated hepatitis (AH) have high mortality. Corticosteroids improve survival only for 30 days. We targeted inflammation, cellular injury, and gut leakiness in a randomized clinical trial comparing combination therapy to corticosteroids on 180-day survival. Approach and Results Subjects with a clinical diagnosis of severe AH (Model for End-Stage Liver Disease [MELD] >20, Maddrey discriminant function [MDF] >32) were randomized to receive methylprednisolone (PRED; 28 days) or a combination of anakinra (14 days) plus pentoxifylline (28 days) plus zinc (COMB; 180 days). The primary endpoint was survival at 180 days. The study was designed in 2013, initiated in October 2014, and completed in March 2018. Five hundred patients were screened to randomize 104 subjects with a clinical diagnosis of AH with a MELD score >20. Fifty-three patients were randomized into the COMB and 50 to the PRED treatment; 1 dropped out of the study before randomization. Mean age was 45.3 ± 10.4 years; 60.6% were males, 92.3% White, and mean MELD 25.7 ± 3.9. Kaplan-Meier survival estimate at 180 days was 67.9% in COMB and 56% in PRED (HR = 0.69; p = 0.3001). Survival curves separated by 90 days (COMB, 69.8%; PRED, 58.0%; HR = 0.69; p = 0.28). Survival at 28 days was similar between the COMB (83.4%) and PRED groups (81.2%; HR = 0.91; p = 0.85). There were no unexpected serious adverse events, and incidence of infection was comparable between groups. MELD 20–25 and MELD >26 strata showed nonsignificant treatment effects in favor of COMB. Conclusions A combination of anakinra, pentoxifylline plus zinc provides similar survival benefits compared to corticosteroid therapy in severe AH." @default.
• W4220821037 created "2022-04-03" @default.
• W4220821037 creator A5006482005 @default.
• W4220821037 creator A5006533887 @default.
• W4220821037 creator A5007342242 @default.
• W4220821037 creator A5008621012 @default.
• W4220821037 creator A5008977415 @default.
• W4220821037 creator A5012100988 @default.
• W4220821037 creator A5018975447 @default.
• W4220821037 creator A5019884281 @default.
• W4220821037 creator A5030524789 @default.
• W4220821037 creator A5067188477 @default.
• W4220821037 creator A5068101019 @default.
• W4220821037 creator A5076434513 @default.
• W4220821037 creator A5083145842 @default.
• W4220821037 creator A5091064969 @default.
• W4220821037 date "2022-06-02" @default.
• W4220821037 modified "2023-10-18" @default.
• W4220821037 title "IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis" @default.
• W4220821037 cites W1951722531 @default.
• W4220821037 cites W1964058014 @default.
• W4220821037 cites W1975752601 @default.
• W4220821037 cites W1986910407 @default.
• W4220821037 cites W2002216094 @default.
• W4220821037 cites W2002221121 @default.
• W4220821037 cites W2006886496 @default.
• W4220821037 cites W2010996301 @default.
• W4220821037 cites W2018630692 @default.
• W4220821037 cites W2022358118 @default.
• W4220821037 cites W2044914971 @default.
• W4220821037 cites W2045867292 @default.
• W4220821037 cites W2047732107 @default.
• W4220821037 cites W2057607705 @default.
• W4220821037 cites W2065157394 @default.
• W4220821037 cites W2066193523 @default.
• W4220821037 cites W2069243984 @default.
• W4220821037 cites W2078644643 @default.
• W4220821037 cites W2093274439 @default.
• W4220821037 cites W2101592596 @default.
• W4220821037 cites W2106706172 @default.
• W4220821037 cites W2139880626 @default.
• W4220821037 cites W2140449647 @default.
• W4220821037 cites W2158056092 @default.
• W4220821037 cites W2286042547 @default.
• W4220821037 cites W2329563581 @default.
• W4220821037 cites W2561573371 @default.
• W4220821037 cites W2564175172 @default.
• W4220821037 cites W2598766819 @default.
• W4220821037 cites W2608495636 @default.
• W4220821037 cites W2616380171 @default.
• W4220821037 cites W2768403718 @default.
• W4220821037 cites W2800637473 @default.
• W4220821037 cites W2909333052 @default.
• W4220821037 cites W2910227631 @default.
• W4220821037 cites W2910709942 @default.
• W4220821037 cites W2988550413 @default.
• W4220821037 cites W3046828453 @default.
• W4220821037 cites W4210605822 @default.
• W4220821037 doi "https://doi.org/10.1002/hep.32478" @default.
• W4220821037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35340032" @default.
• W4220821037 hasPublicationYear "2022" @default.
• W4220821037 type Work @default.
• W4220821037 citedByCount "28" @default.
• W4220821037 countsByYear W42208210372022 @default.
• W4220821037 countsByYear W42208210372023 @default.
• W4220821037 crossrefType "journal-article" @default.
• W4220821037 hasAuthorship W4220821037A5006482005 @default.
• W4220821037 hasAuthorship W4220821037A5006533887 @default.
• W4220821037 hasAuthorship W4220821037A5007342242 @default.
• W4220821037 hasAuthorship W4220821037A5008621012 @default.
• W4220821037 hasAuthorship W4220821037A5008977415 @default.
• W4220821037 hasAuthorship W4220821037A5012100988 @default.
• W4220821037 hasAuthorship W4220821037A5018975447 @default.
• W4220821037 hasAuthorship W4220821037A5019884281 @default.
• W4220821037 hasAuthorship W4220821037A5030524789 @default.
• W4220821037 hasAuthorship W4220821037A5067188477 @default.
• W4220821037 hasAuthorship W4220821037A5068101019 @default.
• W4220821037 hasAuthorship W4220821037A5076434513 @default.
• W4220821037 hasAuthorship W4220821037A5083145842 @default.
• W4220821037 hasAuthorship W4220821037A5091064969 @default.
• W4220821037 hasBestOaLocation W42208210372 @default.
• W4220821037 hasConcept C10515644 @default.
• W4220821037 hasConcept C126322002 @default.
• W4220821037 hasConcept C141071460 @default.
• W4220821037 hasConcept C168563851 @default.
• W4220821037 hasConcept C197934379 @default.
• W4220821037 hasConcept C203092338 @default.
• W4220821037 hasConcept C204243189 @default.
• W4220821037 hasConcept C2780404050 @default.
• W4220821037 hasConcept C71924100 @default.
• W4220821037 hasConcept C90924648 @default.
• W4220821037 hasConceptScore W4220821037C10515644 @default.
• W4220821037 hasConceptScore W4220821037C126322002 @default.
• W4220821037 hasConceptScore W4220821037C141071460 @default.
• W4220821037 hasConceptScore W4220821037C168563851 @default.
• W4220821037 hasConceptScore W4220821037C197934379 @default.
• W4220821037 hasConceptScore W4220821037C203092338 @default.
• W4220821037 hasConceptScore W4220821037C204243189 @default.

• next